514 related articles for article (PubMed ID: 32256950)
21. Advanced Glycation End Products (AGEs) May Be a Striking Link Between Modern Diet and Health.
Gill V; Kumar V; Singh K; Kumar A; Kim JJ
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31861217
[TBL] [Abstract][Full Text] [Related]
22. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
Yang P; Feng J; Peng Q; Liu X; Fan Z
Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
[TBL] [Abstract][Full Text] [Related]
23. A quick, simple method for detecting circulating fluorescent advanced glycation end-products: Correlation with in vitro and in vivo non-enzymatic glycation.
Villa M; Parravano M; Micheli A; Gaddini L; Matteucci A; Mallozzi C; Facchiano F; Malchiodi-Albedi F; Pricci F
Metabolism; 2017 Jun; 71():64-69. PubMed ID: 28521879
[TBL] [Abstract][Full Text] [Related]
24. Advanced Glycation Endproducts as Biomarkers for Risk of Diabetes and Cardiovascular Diseases by Skin Autofluorescence: A Noninvasive Optical Screening.
Paolillo FR; Mattos VS; Borghi-Silva A; Bagnato VS; de Castro Neto JC
Photobiomodul Photomed Laser Surg; 2019 Mar; 37(3):168-174. PubMed ID: 31050947
[No Abstract] [Full Text] [Related]
25. Methods to investigate advanced glycation end-product and their application in clinical practice.
Corica D; Pepe G; Currò M; Aversa T; Tropeano A; Ientile R; Wasniewska M
Methods; 2022 Jul; 203():90-102. PubMed ID: 34942356
[TBL] [Abstract][Full Text] [Related]
26. Caffeic Acid Inhibits the Formation of Advanced Glycation End Products (AGEs) and Mitigates the AGEs-Induced Oxidative Stress and Inflammation Reaction in Human Umbilical Vein Endothelial Cells (HUVECs).
Cao X; Xia Y; Zeng M; Wang W; He Y; Liu J
Chem Biodivers; 2019 Oct; 16(10):e1900174. PubMed ID: 31419039
[TBL] [Abstract][Full Text] [Related]
27. Advanced glycation end-products (AGEs) accumulation in skin: relations with chronic kidney disease-mineral and bone disorder.
França RA; Esteves ABA; Borges CM; Quadros KRDS; Falcão LCN; Caramori JCT; Oliveira RB
J Bras Nefrol; 2017; 39(3):253-260. PubMed ID: 28902232
[TBL] [Abstract][Full Text] [Related]
28. Advanced Glycation End Products in the Pathogenesis of Psoriasis.
Papagrigoraki A; Maurelli M; Del Giglio M; Gisondi P; Girolomoni G
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156622
[TBL] [Abstract][Full Text] [Related]
29. Advanced glycation end products (AGEs) and their involvement in liver disease.
Hyogo H; Yamagishi S
Curr Pharm Des; 2008; 14(10):969-72. PubMed ID: 18473847
[TBL] [Abstract][Full Text] [Related]
30. Measurement of protein glycation, glycated peptides, and glycation free adducts.
Thornalley PJ
Perit Dial Int; 2005; 25(6):522-33. PubMed ID: 16419322
[TBL] [Abstract][Full Text] [Related]
31. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review.
Fishman SL; Sonmez H; Basman C; Singh V; Poretsky L
Mol Med; 2018 Nov; 24(1):59. PubMed ID: 30470170
[TBL] [Abstract][Full Text] [Related]
32. Glycation of antibodies: Modification, methods and potential effects on biological functions.
Wei B; Berning K; Quan C; Zhang YT
MAbs; 2017; 9(4):586-594. PubMed ID: 28272973
[TBL] [Abstract][Full Text] [Related]
33. Minimal invasive fluorescence methods to quantify advanced glycation end products (AGEs) in skin and plasma of humans.
Almengló C; Rodriguez-Ruiz E; Alvarez E; López-Lago A; González-Juanatey JR; Garcia-Allut JL
Methods; 2022 Jul; 203():103-107. PubMed ID: 33412280
[TBL] [Abstract][Full Text] [Related]
34. Methods to assess advanced glycation end-products.
Jaisson S; Gillery P
Curr Opin Clin Nutr Metab Care; 2021 Sep; 24(5):411-415. PubMed ID: 34155155
[TBL] [Abstract][Full Text] [Related]
35. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
36. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
[TBL] [Abstract][Full Text] [Related]
37. Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review.
Bos DC; de Ranitz-Greven WL; de Valk HW
Diabetes Technol Ther; 2011 Jul; 13(7):773-9. PubMed ID: 21510765
[TBL] [Abstract][Full Text] [Related]
38. Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Rutkowska AZ; Diamanti-Kandarakis E
Curr Pharm Des; 2016; 22(36):5558-5571. PubMed ID: 27412301
[TBL] [Abstract][Full Text] [Related]
39. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
40. Dietary advanced glycation end products and their relevance for human health.
Nowotny K; Schröter D; Schreiner M; Grune T
Ageing Res Rev; 2018 Nov; 47():55-66. PubMed ID: 29969676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
